1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:732434 6480464 o, p'-DDT results in increased expression of PRKAR2A mRNA CTD PMID:19371625 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of PRKAR2A mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of PRKAR2A mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:3393 6480464 Ethinyl Estradiol results in increased expression of PRKAR2A mRNA CTD PMID:29097150 17beta-estradiol increases expression ISO RGD:732434 6480464 Estradiol results in increased expression of PRKAR2A mRNA CTD PMID:23019147 2-ethoxyethanol increases expression ISO RGD:3393 6480464 2-ethoxyethanol results in increased expression of PRKAR2A mRNA CTD PMID:19643169 2-methoxyethanol increases expression ISO RGD:3393 6480464 methyl cellosolve results in increased expression of PRKAR2A mRNA CTD PMID:19643169 3',5'-cyclic AMP multiple interactions ISO RGD:3393 6480464 Clozapine inhibits the reaction [Cyclic AMP binds to PRKAR2A protein], Haloperidol promotes the reaction [Cyclic AMP binds to PRKAR2A protein] CTD PMID:11907174 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:3393 6480464 3 more ... CTD PMID:32119087 3-chloropropane-1,2-diol decreases expression ISO RGD:3393 6480464 alpha-Chlorohydrin analog results in decreased expression of PRKAR2A protein CTD PMID:26072098 3H-1,2-dithiole-3-thione increases expression ISO RGD:3393 6480464 1, 2-dithiol-3-thione results in increased expression of PRKAR2A mRNA CTD PMID:19162173 4-vinylcyclohexene dioxide affects expression EXP 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of PRKAR2A mRNA CTD PMID:20829426 6-propyl-2-thiouracil increases expression ISO RGD:3393 6480464 Propylthiouracil results in increased expression of PRKAR2A mRNA CTD PMID:22504374 acrolein multiple interactions ISO RGD:732434 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRKAR2A mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRKAR2A mRNA CTD PMID:32699268 acrylamide decreases expression ISO RGD:3393 6480464 Acrylamide results in decreased expression of PRKAR2A mRNA CTD PMID:28959563 alpha-pinene multiple interactions ISO RGD:732434 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRKAR2A mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRKAR2A mRNA CTD PMID:32699268 amphetamine decreases expression ISO RGD:3393 6480464 Amphetamine results in decreased expression of PRKAR2A mRNA CTD PMID:30779732 amphetamine increases expression ISO RGD:3393 6480464 Amphetamine results in increased expression of PRKAR2A mRNA, Amphetamine results in increased expression of PRKAR2A protein CTD PMID:16896163 amphetamine affects response to substance ISO RGD:3393 6480464 PRKAR2A protein affects the susceptibility to Amphetamine CTD PMID:16896163 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of PRKAR2A mRNA CTD PMID:19654921 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of PRKAR2A mRNA CTD PMID:19654921 benzo[a]pyrene increases expression ISO RGD:3393 6480464 Benzoapyrene results in increased expression of PRKAR2A mRNA CTD PMID:21839799 benzo[a]pyrene increases methylation ISO RGD:732434 6480464 Benzoapyrene results in increased methylation of PRKAR2A promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:732434 6480464 Benzoapyrene affects the methylation of PRKAR2A 3' UTR CTD PMID:27901495 bis(2-chloroethyl) sulfide increases phosphorylation ISO RGD:732434 6480464 Mustard Gas results in increased phosphorylation of PRKAR2A protein CTD PMID:19845377 bisphenol A increases expression ISO RGD:732434 6480464 bisphenol A results in increased expression of PRKAR2A mRNA CTD PMID:19371625 bisphenol A increases expression ISO RGD:3393 6480464 bisphenol A results in increased expression of PRKAR2A mRNA CTD PMID:29097150 , PMID:30816183 bisphenol A decreases expression ISO RGD:3393 6480464 bisphenol A results in decreased expression of PRKAR2A mRNA CTD PMID:25181051 C60 fullerene decreases expression ISO RGD:3393 6480464 fullerene C60 results in decreased expression of PRKAR2A mRNA CTD PMID:19167457 cadmium dichloride increases expression ISO RGD:3393 6480464 Cadmium Chloride results in increased expression of PRKAR2A mRNA CTD PMID:25993096 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRKAR2A gene CTD PMID:20938992 clozapine multiple interactions ISO RGD:3393 6480464 Clozapine inhibits the reaction [Cyclic AMP binds to PRKAR2A protein] CTD PMID:11907174 clozapine decreases expression ISO RGD:3393 6480464 Clozapine results in decreased expression of PRKAR2A mRNA, Clozapine results in decreased expression of PRKAR2A protein CTD PMID:11907174 cobalt dichloride decreases expression ISO RGD:732434 6480464 cobaltous chloride results in decreased expression of PRKAR2A mRNA CTD PMID:19320972 colforsin daropate hydrochloride increases phosphorylation ISO RGD:732434 6480464 Colforsin results in increased phosphorylation of PRKAR2A protein CTD PMID:25943029 deoxynivalenol increases phosphorylation EXP 6480464 deoxynivalenol results in increased phosphorylation of PRKAR2A protein CTD PMID:23352502 diazinon decreases expression ISO RGD:3393 6480464 Diazinon results in decreased expression of PRKAR2A mRNA CTD PMID:17452286 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PRKAR2A mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:732434 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PRKAR2A mRNA CTD PMID:27188386 doxorubicin affects expression ISO RGD:732434 6480464 Doxorubicin affects the expression of PRKAR2A protein CTD PMID:29385562 enzyme inhibitor multiple interactions ISO RGD:732434 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PRKAR2A protein CTD PMID:23301498 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of PRKAR2A mRNA CTD PMID:30319688 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRKAR2A gene CTD PMID:20938992 genistein increases expression ISO RGD:732434 6480464 Genistein results in increased expression of PRKAR2A mRNA CTD PMID:19371625 haloperidol multiple interactions ISO RGD:3393 6480464 Haloperidol promotes the reaction [Cyclic AMP binds to PRKAR2A protein] CTD PMID:11907174 haloperidol increases expression ISO RGD:3393 6480464 Haloperidol results in increased expression of PRKAR2A mRNA, Haloperidol results in increased expression of PRKAR2A protein CTD PMID:11907174 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRKAR2A gene CTD PMID:20938992 methapyrilene decreases expression ISO RGD:3393 6480464 Methapyrilene results in decreased expression of PRKAR2A mRNA CTD PMID:30467583 methimazole increases expression ISO RGD:3393 6480464 Methimazole results in increased expression of PRKAR2A mRNA CTD PMID:22504374 methoxychlor increases methylation ISO RGD:3393 6480464 Methoxychlor results in increased methylation of PRKAR2A gene CTD PMID:23303685 monocrotaline increases expression EXP 6480464 Monocrotaline results in increased expression of PRKAR2A mRNA CTD PMID:28818515 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:732434 6480464 N-2-4-bromocinnamylaminoethyl-5-isoquinolinesulfonamide inhibits the reaction [resveratrol results in increased phosphorylation of PRKAR2A protein] CTD PMID:25943029 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide decreases phosphorylation ISO RGD:732434 6480464 N-2-4-bromocinnamylaminoethyl-5-isoquinolinesulfonamide results in decreased phosphorylation of PRKAR2A protein CTD PMID:25943029 N-nitrosodiethylamine multiple interactions ISO RGD:3393 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PRKAR2A mRNA CTD PMID:20360939 oxaliplatin decreases expression ISO RGD:3393 6480464 oxaliplatin results in decreased expression of PRKAR2A mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:3393 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PRKAR2A mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:732434 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRKAR2A mRNA more ... CTD PMID:32699268 paracetamol decreases expression ISO RGD:732434 6480464 Acetaminophen results in decreased expression of PRKAR2A mRNA CTD PMID:21420995 phenethyl caffeate multiple interactions ISO RGD:3393 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PRKAR2A mRNA CTD PMID:20360939 phenylpropanolamine increases expression ISO RGD:3393 6480464 Phenylpropanolamine results in increased expression of PRKAR2A mRNA, Phenylpropanolamine results in increased expression of PRKAR2A protein CTD PMID:17684035 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PRKAR2A mRNA CTD PMID:17426115 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of PRKAR2A mRNA CTD PMID:23608068 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [POMC protein results in increased phosphorylation of PRKAR2A protein] CTD PMID:21290442 resveratrol increases expression ISO RGD:732434 6480464 resveratrol results in increased expression of PRKAR2A mRNA CTD PMID:19371625 resveratrol multiple interactions ISO RGD:732434 6480464 N-2-4-bromocinnamylaminoethyl-5-isoquinolinesulfonamide inhibits the reaction [resveratrol results in increased phosphorylation of PRKAR2A protein] CTD PMID:25943029 resveratrol increases phosphorylation EXP 6480464 resveratrol results in increased phosphorylation of PRKAR2A protein CTD PMID:25943029 resveratrol increases phosphorylation ISO RGD:732434 6480464 resveratrol results in increased phosphorylation of PRKAR2A protein CTD PMID:25943029 SB 431542 multiple interactions ISO RGD:732434 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PRKAR2A mRNA CTD PMID:27188386 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of PRKAR2A protein CTD PMID:28918527 Soman increases expression ISO RGD:3393 6480464 Soman results in increased expression of PRKAR2A mRNA CTD PMID:19281266 testosterone enanthate decreases expression ISO RGD:3393 6480464 testosterone enanthate results in decreased expression of PRKAR2A mRNA CTD PMID:25603467 testosterone enanthate affects expression ISO RGD:732434 6480464 testosterone enanthate affects the expression of PRKAR2A mRNA CTD PMID:17440010 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of PRKAR2A mRNA CTD PMID:17484886 thioacetamide increases methylation ISO RGD:3393 6480464 Thioacetamide results in increased methylation of PRKAR2A promoter CTD PMID:27914986 topotecan multiple interactions ISO RGD:3393 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PRKAR2A mRNA CTD PMID:25729387 topotecan decreases expression ISO RGD:3393 6480464 Topotecan results in decreased expression of PRKAR2A mRNA CTD PMID:25729387 triclosan decreases expression ISO RGD:732434 6480464 Triclosan results in decreased expression of PRKAR2A mRNA CTD PMID:30510588 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of PRKAR2A mRNA CTD PMID:19042947 valproic acid increases expression ISO RGD:732434 6480464 Valproic Acid results in increased expression of PRKAR2A mRNA CTD PMID:23179753 , PMID:26272509 valproic acid multiple interactions ISO RGD:732434 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PRKAR2A mRNA CTD PMID:27188386 zearalenone increases expression ISO RGD:732434 6480464 Zearalenone results in increased expression of PRKAR2A mRNA CTD PMID:19371625